Global Spatial Genomics and Transcriptomics Market 2024-2028

The spatial genomics and transcriptomics market is forecasted to grow by USD 619.21 mn during 2023-2028, accelerating at a CAGR of 11.22% during the forecast period. The report on the spatial genomics and transcriptomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a surge in the adoption of spatial genomics and transcriptomics in drug discovery and development, rising product launches and strategic alliances by vendors, and the emergence of spatial omics as a technology-driven field.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	9.31%
CAGR	11.22%
Incremental Value	$619.21mn

Technavio's spatial genomics and transcriptomics market is segmented as below:

By Application

Translation research
Drug discovery and development

By Product

Consumables
Instruments

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing use of spatial omics for biomarker identification as one of the prime reasons driving the spatial genomics and transcriptomics market growth during the next few years. Also, the emerging potential of spatial genomics analysis in cancer diagnostics and advances in sequencing technologies will lead to sizable demand in the market.

The report on the spatial genomics and transcriptomics market covers the following areas:

Spatial genomics and transcriptomics market sizing
Spatial genomics and transcriptomics market forecast
Spatial genomics and transcriptomics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading spatial genomics and transcriptomics market vendors that include 10X Genomics Inc., Akoya Biosciences Inc., Bio Rad Laboratories Inc., Bio Techne Corp., BioSpyder Technologies Inc., Cantata Bio LLC, Fulgent Genetics Inc., Illumina Inc., Lunaphore Technologies SA, NanoString Technologies Inc., RareCyte Inc., Rebus Biosystems Inc., Resolve BioSciences GmbH, S2 Genomics Inc., Seven Bridges Genomics Inc., Singular Genomics System Inc., Ultivue Inc., Veranome Biosystems LLC, Vizgen Corp., and PerkinElmer Inc. Also, the spatial genomics and transcriptomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73547

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global spatial genomics and transcriptomics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global spatial genomics and transcriptomics market 2018 - 2022 ($ million)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Translation research - Market size and forecast 2023-2028
Exhibit 34: Chart on Translation research - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Translation research - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Translation research - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Translation research - Year-over-year growth 2023-2028 (%)
6.4 Drug discovery and development - Market size and forecast 2023-2028
Exhibit 38: Chart on Drug discovery and development - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Drug discovery and development - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Drug discovery and development - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Drug discovery and development - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Application
Exhibit 42: Market opportunity by Application ($ million)
Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 44: Chart on Product - Market share 2023-2028 (%)
Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 46: Chart on Comparison by Product
Exhibit 47: Data Table on Comparison by Product
7.3 Consumables - Market size and forecast 2023-2028
Exhibit 48: Chart on Consumables - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Consumables - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Consumables - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
7.4 Instruments - Market size and forecast 2023-2028
Exhibit 52: Chart on Instruments - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Instruments - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Instruments - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Instruments - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Exhibit 56: Market opportunity by Product ($ million)
Exhibit 57: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 10X Genomics Inc.
Exhibit 107: 10X Genomics Inc. - Overview
Exhibit 108: 10X Genomics Inc. - Product / Service
Exhibit 109: 10X Genomics Inc. - Key offerings
12.4 Akoya Biosciences Inc.
Exhibit 110: Akoya Biosciences Inc. - Overview
Exhibit 111: Akoya Biosciences Inc. - Product / Service
Exhibit 112: Akoya Biosciences Inc. - Key offerings
12.5 Bio Rad Laboratories Inc.
Exhibit 113: Bio Rad Laboratories Inc. - Overview
Exhibit 114: Bio Rad Laboratories Inc. - Business segments
Exhibit 115: Bio Rad Laboratories Inc. - Key news
Exhibit 116: Bio Rad Laboratories Inc. - Key offerings
Exhibit 117: Bio Rad Laboratories Inc. - Segment focus
12.6 Bio Techne Corp.
Exhibit 118: Bio Techne Corp. - Overview
Exhibit 119: Bio Techne Corp. - Business segments
Exhibit 120: Bio Techne Corp. - Key offerings
Exhibit 121: Bio Techne Corp. - Segment focus
12.7 Fulgent Genetics Inc.
Exhibit 122: Fulgent Genetics Inc. - Overview
Exhibit 123: Fulgent Genetics Inc. - Product / Service
Exhibit 124: Fulgent Genetics Inc. - Key offerings
12.8 Illumina Inc.
Exhibit 125: Illumina Inc. - Overview
Exhibit 126: Illumina Inc. - Business segments
Exhibit 127: Illumina Inc. - Key news
Exhibit 128: Illumina Inc. - Key offerings
Exhibit 129: Illumina Inc. - Segment focus
12.9 Lunaphore Technologies SA
Exhibit 130: Lunaphore Technologies SA - Overview
Exhibit 131: Lunaphore Technologies SA - Product / Service
Exhibit 132: Lunaphore Technologies SA - Key offerings
12.10 NanoString Technologies Inc.
Exhibit 133: NanoString Technologies Inc. - Overview
Exhibit 134: NanoString Technologies Inc. - Product / Service
Exhibit 135: NanoString Technologies Inc. - Key offerings
12.11 PerkinElmer Inc
Exhibit 136: PerkinElmer Inc - Overview
Exhibit 137: PerkinElmer Inc - Business segments
Exhibit 138: PerkinElmer Inc - Key news
Exhibit 139: PerkinElmer Inc - Key offerings
Exhibit 140: PerkinElmer Inc - Segment focus
12.12 RareCyte Inc.
Exhibit 141: RareCyte Inc. - Overview
Exhibit 142: RareCyte Inc. - Product / Service
Exhibit 143: RareCyte Inc. - Key offerings
12.13 Rebus Biosystems Inc.
Exhibit 144: Rebus Biosystems Inc. - Overview
Exhibit 145: Rebus Biosystems Inc. - Product / Service
Exhibit 146: Rebus Biosystems Inc. - Key offerings
12.14 Resolve BioSciences GmbH
Exhibit 147: Resolve BioSciences GmbH - Overview
Exhibit 148: Resolve BioSciences GmbH - Product / Service
Exhibit 149: Resolve BioSciences GmbH - Key offerings
12.15 S2 Genomics Inc.
Exhibit 150: S2 Genomics Inc. - Overview
Exhibit 151: S2 Genomics Inc. - Product / Service
Exhibit 152: S2 Genomics Inc. - Key offerings
12.16 Seven Bridges Genomics Inc.
Exhibit 153: Seven Bridges Genomics Inc. - Overview
Exhibit 154: Seven Bridges Genomics Inc. - Product / Service
Exhibit 155: Seven Bridges Genomics Inc. - Key offerings
12.17 Veranome Biosystems LLC
Exhibit 156: Veranome Biosystems LLC - Overview
Exhibit 157: Veranome Biosystems LLC - Product / Service
Exhibit 158: Veranome Biosystems LLC - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 159: Inclusions checklist
Exhibit 160: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 161: Currency conversion rates for US$
13.4 Research methodology
Exhibit 162: Research methodology
Exhibit 163: Validation techniques employed for market sizing
Exhibit 164: Information sources
13.5 List of abbreviations
Exhibit 165: List of abbreviations